Talaris Therapeutics, Inc. Uncategorized Contracts & Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Confirmatory offer letter, by and between the Registrant and Ryan Robinson, dated June 25, 2024
Talaris Therapeutics, Inc.
Biotechnology
2024
Description of Securities
Talaris Therapeutics, Inc.
Biotechnology
2024
Side Letter, dated as of November 10, 2023, by and between the Registrant and Ryan Robinson
Talaris Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated as of June 7, 2023, by and between Tourmaline Bio, Inc. and Ryan Robinson
Talaris Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Susan Dana Jones, Ph.D
Talaris Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Brad Middlekauff, M.D
Talaris Therapeutics, Inc.
Biotechnology
2023
Offer Letter, dated as of October 18, 2023, by and between Tourmaline Bio, Inc. and Sandeep Kulkarni, M.D
Talaris Therapeutics, Inc.
Biotechnology
2023
Strategic Advisor Agreement, by and between the Registrant and Scott Requadt, dated May 26, 2023
Talaris Therapeutics, Inc.
Biotechnology
KY
2023
Form of Lock-Up Agreement
Talaris Therapeutics, Inc.
Biotechnology
2023
Forms of Talaris Support Agreements
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
Form of Tourmaline Support Agreement
Talaris Therapeutics, Inc.
Biotechnology
NY
2023
Description of Securities
Talaris Therapeutics, Inc.
Biotechnology
DE
2022
Offer Letter, by and between the Registrant and Mary Kay Fenton, as amended, dated January 21, 2021
Talaris Therapeutics, Inc.
Biotechnology
2021
Offer Letter, by and between the Registrant and Michael Zdanowski, dated September 29, 2020
Talaris Therapeutics, Inc.
Biotechnology
2021
Offer Letter, by and between the Registrant and Nancy Krieger, dated November 1, 2018
Talaris Therapeutics, Inc.
Biotechnology
DE
2021